Status:
UNKNOWN
Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.
Lead Sponsor:
Nada Yousef
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the effectiveness of low level laser on radiotherapy induced xerostomia to improve oral function and decrease oral complication due to hyposalivation and thus e...
Detailed Description
In this part of the study, the materials and methods will be presented under the following headings: subjects, equipment, procedures of the study and the statistical procedures. 1. Subjects: Sixt...
Eligibility Criteria
Inclusion
- \- Age range between 25-55 years.
- All patients included in the study established HNC and will receive radiotherapy encompassing major salivary glands accompanied or not by surgery.
- All patients enrolled to the study will have their informed consent.
- Both genders will participate in the study.
- All the patients were examined medically by oncologist
Exclusion
- \- Diabetes mellitus,
- Autoimmune diseases as sjorgen syndrome by established diagnosis criteria.
- Infectious diseases
- Collagen diseases, as were those with incipient tumors (stage T1 or T2) limited to the larynx, as well as those with trismus (reduced mouth opening capacity) due to surgical sequelae.
- xerostomic drugs (antiretroviral medications, antihistamines, anticholinergics, antihypertensives, decongestants, narcotic analgesics, tricyclic antidepressants)
Key Trial Info
Start Date :
September 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04700475
Start Date
September 4 2020
End Date
February 1 2021
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university
Giza, Egypt